Deciphering keloid formation and treatment: insights from mechanobiology

Clicks: 3
ID: 322671
2026
Article Quality & Performance Metrics
Overall Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Keloids are benign fibroproliferative disorders characterised by raised dermal lesions that extend beyond original wound margins, often causing pain, pruritus, and significant aesthetic impairment. The aetiology of keloid formation is multifactorial, encompassing genetic predispositions, dysregulated inflammation, and aberrant mechanical forces. Despite advances in therapeutic modalities, current clinical management strategies-such as silicone gel sheets, intralesional corticosteroids, surgical excision, and adjuvant radiotherapy-often yield variable efficacy. With recurrence rates frequently exceeding 50% following monotherapy, preventing recurrence remains a major clinical challenge. This review comprehensively examines the mechanobiology of keloid formation, exploring how physical tension and extracellular matrix (ECM) stiffness dictate disease progression. A central focus is the mechanosensory-immune axis, which perpetuates a vicious, self-reinforcing mechanics-inflammation-fibrosis feedback loop. We systematically decipher the key signalling cascades responsible for this mechanotransduction, specifically highlighting the TGF-β/Smad network, integrin-focal adhesion kinase (FAK)-mediated signalling, intracellular calcium flux, and the critical Hippo-YAP/TAZ pathway. Furthermore, the role of the mechanosensitive ion channel Piezo1 and the convergence of mechanical and immunological signals via the JAK-STAT axis are evaluated in depth. By elucidating these complex networks, we identify promising, mechanism-informed therapeutic avenues, including FAK, YAP, and JAK inhibitors. Crucially, we highlight the paradigm-shifting potential of targeting both membrane and nuclear mechanics-intracellular mechanical memory-to explain and curb the clinical intractability of keloids. Ultimately, translating these mechanobiological insights into biomarker-stratified clinical trials will drive a critical shift toward precision mechanomedicine, holding profound potential to dismantle mechanical memory, prevent recurrence, and improve patients' quality of life.
Reference Key
openalex_W7171438938 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yi-Han Chang, Joanne Jerenice J Añonuevo, Shih-Wei Jao, Yi‐Kai Hong, Sharon Hsu, Rei Ogawa, Chao‐Kai Hsu
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag307
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.